Global Next Generation Sequencing (NGS) Solution Market Research Report 2025(Status and Outlook)

March 2025 | 183 pages | ID: G4E626CA54FFEN
Bosson Research

Abstracts

Report Overview

Next Generation Sequencing (NGS), also known as high-throughput sequencing, refers to advanced genomic technologies that enable the rapid and cost-effective sequencing of DNA or RNA molecules. NGS solutions have revolutionized the field of genomics and have significant applications in various areas of life sciences, including medical research, diagnostics, personalized medicine, agriculture, and environmental studies.

This report provides a deep insight into the global Next Generation Sequencing (NGS) Solution market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Next Generation Sequencing (NGS) Solution Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Next Generation Sequencing (NGS) Solution market in any manner.

Global Next Generation Sequencing (NGS) Solution Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Eurofins Scientific

Illumina

PerkinElmer

Thermo Fisher Scientific

Roche Holding

Agilent Technologies

Myriad Genetics

Foundation Medicine

Oxford Nanopore Technologies

Pacific Biosciences

Paradigm Diagnostics

BGI Group

Caris Life Sciences

Partek

Natera

LabCorp

Macrogen

Genotypic Technology

Market Segmentation (by Type)

Whole Genome Sequencing

Whole Exome Sequencing

Targeted Sequencing and Resequencing Centrifuges

Market Segmentation (by Application)

Sporadic Cancer

Inherited Cancer

Companion Diagnostics

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Next Generation Sequencing (NGS) Solution Market
• Overview of the regional outlook of the Next Generation Sequencing (NGS) Solution Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Next Generation Sequencing (NGS) Solution Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Next Generation Sequencing (NGS) Solution
1.2 Key Market Segments
  1.2.1 Next Generation Sequencing (NGS) Solution Segment by Type
  1.2.2 Next Generation Sequencing (NGS) Solution Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GLOBAL NEXT GENERATION SEQUENCING (NGS) SOLUTION MARKET OVERVIEW

2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GLOBAL NEXT GENERATION SEQUENCING (NGS) SOLUTION MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Next Generation Sequencing (NGS) Solution Product Life Cycle
3.3 Global Next Generation Sequencing (NGS) Solution Revenue Market Share by Company (2020-2025)
3.4 Next Generation Sequencing (NGS) Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Next Generation Sequencing (NGS) Solution Company Headquarters, Area Served, Product Type
3.6 Next Generation Sequencing (NGS) Solution Market Competitive Situation and Trends
  3.6.1 Next Generation Sequencing (NGS) Solution Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Next Generation Sequencing (NGS) Solution Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 DEVELOPMENT AND DYNAMICS OF NEXT GENERATION SEQUENCING (NGS) SOLUTION MARKET

4.1 Key Development Trends
4.2 Driving Factors
4.3 Market Challenges
4.4 Market Restraints
4.5 Industry News
  4.5.1 New Product Developments
  4.5.2 Mergers & Acquisitions
  4.5.3 Expansions
  4.5.4 Collaboration/Supply Contracts
4.6 PEST Analysis
  4.6.1 Industry Policies Analysis
  4.6.2 Economic Environment Analysis
  4.6.3 Social Environment Analysis
  4.6.4 Technological Environment Analysis
4.7 Global Next Generation Sequencing (NGS) Solution Market Porter's Five Forces Analysis

5 GLOBAL NEXT GENERATION SEQUENCING (NGS) SOLUTION MARKET SEGMENTATION BY REGION

5.1 Global Next Generation Sequencing (NGS) Solution Market Size by Region
5.2 Global Next Generation Sequencing (NGS) Solution Market Size by Country

6 NORTH AMERICA MARKET OVERVIEW

6.1 North America Next Generation Sequencing (NGS) Solution Market Size by Country
  6.1.1 USA Market Overview
  6.1.2 Canada Market Overview
  6.1.3 Mexico Market Overview
6.2 North America Next Generation Sequencing (NGS) Solution Market Size by Type
6.3 North America Next Generation Sequencing (NGS) Solution Market Size by Application

7 EUROPE MARKET OVERVIEW

7.1 Europe Next Generation Sequencing (NGS) Solution Market Size by Country
  7.1.1 Germany Market Overview
  7.1.2 France Market Overview
  7.1.3 U.K. Market Overview
  7.1.4 Italy Market Overview
  7.1.5 Spain Market Overview
7.2 Europe Next Generation Sequencing (NGS) Solution Market Size by Type
7.3 Europe Next Generation Sequencing (NGS) Solution Market Size by Application

8 ASIA-PACIFIC MARKET OVERVIEW

8.1 Asia-Pacific Next Generation Sequencing (NGS) Solution Market Size by Country
  8.1.1 China Market Overview
  8.1.2 Japan Market Overview
  8.1.3 South Korea Market Overview
  8.1.4 India Market Overview
  8.1.5 Southeast Asia Market Overview
8.2 Asia-Pacific Next Generation Sequencing (NGS) Solution Market Size by Type
8.3 Asia-Pacific Next Generation Sequencing (NGS) Solution Market Size by Application

9 SOUTH AMERICA MARKET OVERVIEW

9.1 South America Next Generation Sequencing (NGS) Solution Market Size by Country
  9.1.1 Brazil Market Overview
  9.1.2 Argentina Market Overview
  9.1.3 Columbia Market Overview
9.2 South America Next Generation Sequencing (NGS) Solution Market Size by Type
9.3 South America Next Generation Sequencing (NGS) Solution Market Size by Application

10 MIDDLE EAST AND AFRICA MARKET OVERVIEW

10.1 Middle East and Africa Next Generation Sequencing (NGS) Solution Market Size by Country
  10.1.1 Saudi Arabia Market Overview
  10.1.2 UAE Market Overview
  10.1.3 Egypt Market Overview
  10.1.4 Nigeria Market Overview
  10.1.5 South Africa Market Overview
10.2 Middle East and Africa Next Generation Sequencing (NGS) Solution Market Size by Type
10.3 Middle East and Africa Next Generation Sequencing (NGS) Solution Market Size by Application

11 NEXT GENERATION SEQUENCING (NGS) SOLUTION MARKET SEGMENTATION BY TYPE

11.1 Evaluation Matrix of Segment Market Development Potential (Type)
11.2 Global Next Generation Sequencing (NGS) Solution Market Share by Type (2020-2033)
11.3 Global Next Generation Sequencing (NGS) Solution Growth Rate by Type (2020-2033)

12 NEXT GENERATION SEQUENCING (NGS) SOLUTION MARKET SEGMENTATION BY APPLICATION

12.1 Evaluation Matrix of Segment Market Development Potential (Application)
12.2 Global Next Generation Sequencing (NGS) Solution Market Size (M USD) by Application (2020-2033)
12.3 Global Next Generation Sequencing (NGS) Solution Growth Rate by Application (2020-2033)

13 KEY COMPANIES PROFILE

13.1 Eurofins Scientific
  13.1.1 Eurofins Scientific Basic Information
  13.1.2 Eurofins Scientific Next Generation Sequencing (NGS) Solution Product Overview
  13.1.3 Eurofins Scientific Next Generation Sequencing (NGS) Solution Product Market Performance
  13.1.4 Eurofins Scientific Next Generation Sequencing (NGS) Solution SWOT Analysis
  13.1.5 Eurofins Scientific Business Overview
  13.1.6 Eurofins Scientific Recent Developments
13.2 Illumina
  13.2.1 Illumina Basic Information
  13.2.2 Illumina Next Generation Sequencing (NGS) Solution Product Overview
  13.2.3 Illumina Next Generation Sequencing (NGS) Solution Product Market Performance
  13.2.4 Illumina Next Generation Sequencing (NGS) Solution SWOT Analysis
  13.2.5 Illumina Business Overview
  13.2.6 Illumina Recent Developments
13.3 PerkinElmer
  13.3.1 PerkinElmer Basic Information
  13.3.2 PerkinElmer Next Generation Sequencing (NGS) Solution Product Overview
  13.3.3 PerkinElmer Next Generation Sequencing (NGS) Solution Product Market Performance
  13.3.4 PerkinElmer Next Generation Sequencing (NGS) Solution SWOT Analysis
  13.3.5 PerkinElmer Business Overview
  13.3.6 PerkinElmer Recent Developments
13.4 Thermo Fisher Scientific
  13.4.1 Thermo Fisher Scientific Basic Information
  13.4.2 Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Product Overview
  13.4.3 Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Product Market Performance
  13.4.4 Thermo Fisher Scientific Business Overview
  13.4.5 Thermo Fisher Scientific Recent Developments
13.5 Roche Holding
  13.5.1 Roche Holding Basic Information
  13.5.2 Roche Holding Next Generation Sequencing (NGS) Solution Product Overview
  13.5.3 Roche Holding Next Generation Sequencing (NGS) Solution Product Market Performance
  13.5.4 Roche Holding Business Overview
  13.5.5 Roche Holding Recent Developments
13.6 Agilent Technologies
  13.6.1 Agilent Technologies Basic Information
  13.6.2 Agilent Technologies Next Generation Sequencing (NGS) Solution Product Overview
  13.6.3 Agilent Technologies Next Generation Sequencing (NGS) Solution Product Market Performance
  13.6.4 Agilent Technologies Business Overview
  13.6.5 Agilent Technologies Recent Developments
13.7 Myriad Genetics
  13.7.1 Myriad Genetics Basic Information
  13.7.2 Myriad Genetics Next Generation Sequencing (NGS) Solution Product Overview
  13.7.3 Myriad Genetics Next Generation Sequencing (NGS) Solution Product Market Performance
  13.7.4 Myriad Genetics Business Overview
  13.7.5 Myriad Genetics Recent Developments
13.8 Foundation Medicine
  13.8.1 Foundation Medicine Basic Information
  13.8.2 Foundation Medicine Next Generation Sequencing (NGS) Solution Product Overview
  13.8.3 Foundation Medicine Next Generation Sequencing (NGS) Solution Product Market Performance
  13.8.4 Foundation Medicine Business Overview
  13.8.5 Foundation Medicine Recent Developments
13.9 Oxford Nanopore Technologies
  13.9.1 Oxford Nanopore Technologies Basic Information
  13.9.2 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Product Overview
  13.9.3 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Product Market Performance
  13.9.4 Oxford Nanopore Technologies Business Overview
  13.9.5 Oxford Nanopore Technologies Recent Developments
13.10 Pacific Biosciences
  13.10.1 Pacific Biosciences Basic Information
  13.10.2 Pacific Biosciences Next Generation Sequencing (NGS) Solution Product Overview
  13.10.3 Pacific Biosciences Next Generation Sequencing (NGS) Solution Product Market Performance
  13.10.4 Pacific Biosciences Business Overview
  13.10.5 Pacific Biosciences Recent Developments
13.11 Paradigm Diagnostics
  13.11.1 Paradigm Diagnostics Basic Information
  13.11.2 Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Product Overview
  13.11.3 Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Product Market Performance
  13.11.4 Paradigm Diagnostics Business Overview
  13.11.5 Paradigm Diagnostics Recent Developments
13.12 BGI Group
  13.12.1 BGI Group Basic Information
  13.12.2 BGI Group Next Generation Sequencing (NGS) Solution Product Overview
  13.12.3 BGI Group Next Generation Sequencing (NGS) Solution Product Market Performance
  13.12.4 BGI Group Business Overview
  13.12.5 BGI Group Recent Developments
13.13 Caris Life Sciences
  13.13.1 Caris Life Sciences Basic Information
  13.13.2 Caris Life Sciences Next Generation Sequencing (NGS) Solution Product Overview
  13.13.3 Caris Life Sciences Next Generation Sequencing (NGS) Solution Product Market Performance
  13.13.4 Caris Life Sciences Business Overview
  13.13.5 Caris Life Sciences Recent Developments
13.14 Partek
  13.14.1 Partek Basic Information
  13.14.2 Partek Next Generation Sequencing (NGS) Solution Product Overview
  13.14.3 Partek Next Generation Sequencing (NGS) Solution Product Market Performance
  13.14.4 Partek Business Overview
  13.14.5 Partek Recent Developments
13.15 Natera
  13.15.1 Natera Basic Information
  13.15.2 Natera Next Generation Sequencing (NGS) Solution Product Overview
  13.15.3 Natera Next Generation Sequencing (NGS) Solution Product Market Performance
  13.15.4 Natera Business Overview
  13.15.5 Natera Recent Developments
13.16 LabCorp
  13.16.1 LabCorp Basic Information
  13.16.2 LabCorp Next Generation Sequencing (NGS) Solution Product Overview
  13.16.3 LabCorp Next Generation Sequencing (NGS) Solution Product Market Performance
  13.16.4 LabCorp Business Overview
  13.16.5 LabCorp Recent Developments
13.17 Macrogen
  13.17.1 Macrogen Basic Information
  13.17.2 Macrogen Next Generation Sequencing (NGS) Solution Product Overview
  13.17.3 Macrogen Next Generation Sequencing (NGS) Solution Product Market Performance
  13.17.4 Macrogen Business Overview
  13.17.5 Macrogen Recent Developments
13.18 Genotypic Technology
  13.18.1 Genotypic Technology Basic Information
  13.18.2 Genotypic Technology Next Generation Sequencing (NGS) Solution Product Overview
  13.18.3 Genotypic Technology Next Generation Sequencing (NGS) Solution Product Market Performance
  13.18.4 Genotypic Technology Business Overview
  13.18.5 Genotypic Technology Recent Developments

14 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Next Generation Sequencing (NGS) Solution Market Size by Type (M USD)
Table 4. Global Next Generation Sequencing (NGS) Solution Market Size by Application (M USD)
Table 5. Next Generation Sequencing (NGS) Solution Market Size Comparison by Region (M USD)
Table 6. Global Next Generation Sequencing (NGS) Solution Revenue (M USD) by Company (2020-2025)
Table 7. Global Next Generation Sequencing (NGS) Solution Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Sequencing (NGS) Solution as of 2024)
Table 9. Next Generation Sequencing (NGS) Solution Company Headquarters and Area Served
Table 10. Company Next Generation Sequencing (NGS) Solution Product Type
Table 11. Global Next Generation Sequencing (NGS) Solution Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Key Development Trends
Table 14. Driving Factors
Table 15. Next Generation Sequencing (NGS) Solution Market Challenges
Table 16. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 17. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 18. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 19. Next Generation Sequencing (NGS) Solution Market Size Comparison by Region (M USD)
Table 20. Global Next Generation Sequencing (NGS) Solution Market Size by Region (2020-2033) & (M USD)
Table 21. Global Next Generation Sequencing (NGS) Solution Market Share by Region (2020-2025)
Table 22. North America Next Generation Sequencing (NGS) Solution Market Size by Country (2020-2033) & (M USD)
Table 23. North America Next Generation Sequencing (NGS) Solution Market Size by Type (M USD)
Table 24. North America Next Generation Sequencing (NGS) Solution Market Size (M USD) by Type (2020-2033)
Table 25. North America Next Generation Sequencing (NGS) Solution Market Size by Application (M USD)
Table 26. North America Next Generation Sequencing (NGS) Solution Market Size (M USD) by Application (2020-2033)
Table 27. Europe Next Generation Sequencing (NGS) Solution Market Size by Country (2020-2033) & (M USD)
Table 28. Europe Next Generation Sequencing (NGS) Solution Market Size by Type (M USD)
Table 29. Europe Next Generation Sequencing (NGS) Solution Market Size (M USD) by Type (2020-2033)
Table 30. Europe Next Generation Sequencing (NGS) Solution Market Size by Application (M USD)
Table 31. Europe Next Generation Sequencing (NGS) Solution Market Size (M USD) by Application (2020-2033)
Table 32. Asia-Pacific Next Generation Sequencing (NGS) Solution Market Size by Country (2020-2025) & (M USD)
Table 33. Asia-Pacific Next Generation Sequencing (NGS) Solution Market Size by Type (M USD)
Table 34. Asia-Pacific Next Generation Sequencing (NGS) Solution Market Size (M USD) by Type (2020-2025)
Table 35. Asia-Pacific Next Generation Sequencing (NGS) Solution Market Size by Application (M USD)
Table 36. Asia-Pacific Next Generation Sequencing (NGS) Solution Market Size (M USD) by Application (2020-2025)
Table 37. South America Next Generation Sequencing (NGS) Solution Market Size by Country (2020-2033) & (M USD)
Table 38. South America Next Generation Sequencing (NGS) Solution Market Size by Type (M USD)
Table 39. South America Next Generation Sequencing (NGS) Solution Market Size (M USD) by Type (2020-2033)
Table 40. South America Next Generation Sequencing (NGS) Solution Market Size by Application (M USD)
Table 41. South America Next Generation Sequencing (NGS) Solution Market Size (M USD) by Application (2020-2033)
Table 42. Middle East and Africa Next Generation Sequencing (NGS) Solution Market Size by Country (2020-2033) & (M USD)
Table 43. Middle East and Africa Next Generation Sequencing (NGS) Solution Market Size by Type (M USD)
Table 44. Middle East and Africa Next Generation Sequencing (NGS) Solution Market Size (M USD) by Type (2020-2033)
Table 45. Middle East and Africa Next Generation Sequencing (NGS) Solution Market Size by Application (M USD)
Table 46. Middle East and Africa Next Generation Sequencing (NGS) Solution Market Size (M USD) by Application (2020-2033)
Table 47. Global Next Generation Sequencing (NGS) Solution Market Size by Type (M USD)
Table 48. Global Next Generation Sequencing (NGS) Solution Market Size (M USD) by Type (2020-2033)
Table 49. Global Next Generation Sequencing (NGS) Solution Market Share by Type (2020-2033)
Table 50. Global Next Generation Sequencing (NGS) Solution Market Size by Application(M USD)
Table 51. Global Next Generation Sequencing (NGS) Solution Market Size by Application (2020-2033) & (M USD)
Table 52. Global Next Generation Sequencing (NGS) Solution Market Share by Application (2020-2033)
Table 53. Global Next Generation Sequencing (NGS) Solution Growth Rate by Application (2020-2033)
Table 54. Eurofins Scientific Basic Information
Table 55. Eurofins Scientific Next Generation Sequencing (NGS) Solution Product Overview
Table 56. Eurofins Scientific Next Generation Sequencing (NGS) Solution Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Eurofins Scientific Next Generation Sequencing (NGS) Solution SWOT Analysis
Table 58. Eurofins Scientific Business Overview
Table 59. Eurofins Scientific Recent Developments
Table 60. Illumina Basic Information
Table 61. Illumina Next Generation Sequencing (NGS) Solution Product Overview
Table 62. Illumina Next Generation Sequencing (NGS) Solution Revenue (M USD) and Gross Margin (2020-2025)
Table 63. Illumina Next Generation Sequencing (NGS) Solution SWOT Analysis
Table 64. Illumina Business Overview
Table 65. Illumina Recent Developments
Table 66. PerkinElmer Basic Information
Table 67. PerkinElmer Next Generation Sequencing (NGS) Solution Product Overview
Table 68. PerkinElmer Next Generation Sequencing (NGS) Solution Revenue (M USD) and Gross Margin (2020-2025)
Table 69. PerkinElmer Next Generation Sequencing (NGS) Solution SWOT Analysis
Table 70. PerkinElmer Business Overview
Table 71. PerkinElmer Recent Developments
Table 72. Thermo Fisher Scientific Basic Information
Table 73. Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Product Overview
Table 74. Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Revenue (M USD) and Gross Margin (2020-2025)
Table 75. Thermo Fisher Scientific Business Overview
Table 76. Thermo Fisher Scientific Recent Developments
Table 77. Roche Holding Basic Information
Table 78. Roche Holding Next Generation Sequencing (NGS) Solution Product Overview
Table 79. Roche Holding Next Generation Sequencing (NGS) Solution Revenue (M USD) and Gross Margin (2020-2025)
Table 80. Roche Holding Business Overview
Table 81. Roche Holding Recent Developments
Table 82. Agilent Technologies Basic Information
Table 83. Agilent Technologies Next Generation Sequencing (NGS) Solution Product Overview
Table 84. Agilent Technologies Next Generation Sequencing (NGS) Solution Revenue (M USD) and Gross Margin (2020-2025)
Table 85. Agilent Technologies Business Overview
Table 86. Agilent Technologies Recent Developments
Table 87. Myriad Genetics Basic Information
Table 88. Myriad Genetics Next Generation Sequencing (NGS) Solution Product Overview
Table 89. Myriad Genetics Next Generation Sequencing (NGS) Solution Revenue (M USD) and Gross Margin (2020-2025)
Table 90. Myriad Genetics Business Overview
Table 91. Myriad Genetics Recent Developments
Table 92. Foundation Medicine Basic Information
Table 93. Foundation Medicine Next Generation Sequencing (NGS) Solution Product Overview
Table 94. Foundation Medicine Next Generation Sequencing (NGS) Solution Revenue (M USD) and Gross Margin (2020-2025)
Table 95. Foundation Medicine Business Overview
Table 96. Foundation Medicine Recent Developments
Table 97. Oxford Nanopore Technologies Basic Information
Table 98. Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Product Overview
Table 99. Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Revenue (M USD) and Gross Margin (2020-2025)
Table 100. Oxford Nanopore Technologies Business Overview
Table 101. Oxford Nanopore Technologies Recent Developments
Table 102. Pacific Biosciences Basic Information
Table 103. Pacific Biosciences Next Generation Sequencing (NGS) Solution Product Overview
Table 104. Pacific Biosciences Next Generation Sequencing (NGS) Solution Revenue (M USD) and Gross Margin (2020-2025)
Table 105. Pacific Biosciences Business Overview
Table 106. Pacific Biosciences Recent Developments
Table 107. Paradigm Diagnostics Basic Information
Table 108. Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Product Overview
Table 109. Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Revenue (M USD) and Gross Margin (2020-2025)
Table 110. Paradigm Diagnostics Business Overview
Table 111. Paradigm Diagnostics Recent Developments
Table 112. BGI Group Basic Information
Table 113. BGI Group Next Generation Sequencing (NGS) Solution Product Overview
Table 114. BGI Group Next Generation Sequencing (NGS) Solution Revenue (M USD) and Gross Margin (2020-2025)
Table 115. BGI Group Business Overview
Table 116. BGI Group Recent Developments
Table 117. Caris Life Sciences Basic Information
Table 118. Caris Life Sciences Next Generation Sequencing (NGS) Solution Product Overview
Table 119. Caris Life Sciences Next Generation Sequencing (NGS) Solution Revenue (M USD) and Gross Margin (2020-2025)
Table 120. Caris Life Sciences Business Overview
Table 121. Caris Life Sciences Recent Developments
Table 122. Partek Basic Information
Table 123. Partek Next Generation Sequencing (NGS) Solution Product Overview
Table 124. Partek Next Generation Sequencing (NGS) Solution Revenue (M USD) and Gross Margin (2020-2025)
Table 125. Partek Business Overview
Table 126. Partek Recent Developments
Table 127. Natera Basic Information
Table 128. Natera Next Generation Sequencing (NGS) Solution Product Overview
Table 129. Natera Next Generation Sequencing (NGS) Solution Revenue (M USD) and Gross Margin (2020-2025)
Table 130. Natera Business Overview
Table 131. Natera Recent Developments
Table 132. LabCorp Basic Information
Table 133. LabCorp Next Generation Sequencing (NGS) Solution Product Overview
Table 134. LabCorp Next Generation Sequencing (NGS) Solution Revenue (M USD) and Gross Margin (2020-2025)
Table 135. LabCorp Business Overview
Table 136. LabCorp Recent Developments
Table 137. Macrogen Basic Information
Table 138. Macrogen Next Generation Sequencing (NGS) Solution Product Overview
Table 139. Macrogen Next Generation Sequencing (NGS) Solution Revenue (M USD) and Gross Margin (2020-2025)
Table 140. Macrogen Business Overview
Table 141. Macrogen Recent Developments
Table 142. Genotypic Technology Basic Information
Table 143. Genotypic Technology Next Generation Sequencing (NGS) Solution Product Overview
Table 144. Genotypic Technology Next Generation Sequencing (NGS) Solution Revenue (M USD) and Gross Margin (2020-2025)
Table 145. Genotypic Technology Business Overview
Table 146. Genotypic Technology Recent Developments
List of Figures
Figure 1. Industry Chain of Next Generation Sequencing (NGS) Solution
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Next Generation Sequencing (NGS) Solution Market Size (M USD), 2024-2033
Figure 5. Global Next Generation Sequencing (NGS) Solution Market Size (M USD) (2020-2033)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Next Generation Sequencing (NGS) Solution Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Next Generation Sequencing (NGS) Solution Product Life Cycle
Figure 12. Global Next Generation Sequencing (NGS) Solution Revenue Share by Company in 2024
Figure 13. Next Generation Sequencing (NGS) Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 14. The Global 5 and 10 Largest Players: Market Share by Next Generation Sequencing (NGS) Solution Revenue in 2024
Figure 15. Global Next Generation Sequencing (NGS) Solution Market PESTE Analysis
Figure 16. Global Next Generation Sequencing (NGS) Solution Market Porter's Five Forces Analysis
Figure 17. Evaluation Matrix of Regional Market Development Potential
Figure 18. Global Next Generation Sequencing (NGS) Solution Market Size by Region
Figure 19. Global Next Generation Sequencing (NGS) Solution Market Size by Country (M USD)
Figure 20. North American Market Snapshot
Figure 21. North America Next Generation Sequencing (NGS) Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 22. North America Next Generation Sequencing (NGS) Solution Market Size (M USD) by Country
Figure 23. USA Next Generation Sequencing (NGS) Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 24. Canada Next Generation Sequencing (NGS) Solution Market Size (M USD) and Growth Rate (2020-2033)
Figure 25. Mexico Next Generation Sequencing (NGS) Solution Market Size (M USD) and Growth Rate (2020-2033)
Figure 26. North America Next Generation Sequencing (NGS) Solution Market Size (M USD) by Type
Figure 27. North America Next Generation Sequencing (NGS) Solution Market Size (M USD) by Application
Figure 28. Europe Market Snapshot
Figure 29. Europe Next Generation Sequencing (NGS) Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 30. Europe Next Generation Sequencing (NGS) Solution Market Size (M USD) by Country
Figure 31. Germany Next Generation Sequencing (NGS) Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. France Next Generation Sequencing (NGS) Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 33. U.K. Next Generation Sequencing (NGS) Solution Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Italy Next Generation Sequencing (NGS) Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Spain Next Generation Sequencing (NGS) Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 36. Europe Next Generation Sequencing (NGS) Solution Market Size (M USD) by Type
Figure 37. Europe Next Generation Sequencing (NGS) Solution Market Size (M USD) by Application
Figure 38. Asia-Pacific Market Snapshot
Figure 39. Asia-Pacific Next Generation Sequencing (NGS) Solution Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia-Pacific Next Generation Sequencing (NGS) Solution Market Size (M USD) by Country
Figure 41. China Next Generation Sequencing (NGS) Solution Market Size and Growth Rate (2020-2025) & (M USD)
Figure 42. Japan Next Generation Sequencing (NGS) Solution Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. South Korea Next Generation Sequencing (NGS) Solution Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. India Next Generation Sequencing (NGS) Solution Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. Southeast Asia Next Generation Sequencing (NGS) Solution Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Asia-Pacific Next Generation Sequencing (NGS) Solution Market Size (M USD) by Type
Figure 47. Asia-Pacific Next Generation Sequencing (NGS) Solution Market Size (M USD) by Application
Figure 48. South America Market Snapshot
Figure 49. South America Next Generation Sequencing (NGS) Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 50. South America Next Generation Sequencing (NGS) Solution Market Size (M USD) by Country
Figure 51. Brazil Next Generation Sequencing (NGS) Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 52. Argentina Next Generation Sequencing (NGS) Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Columbia Next Generation Sequencing (NGS) Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 54. South America Next Generation Sequencing (NGS) Solution Market Size (M USD) by Type
Figure 55. South America Next Generation Sequencing (NGS) Solution Market Size (M USD) by Application
Figure 56. Middle East and Africa Market Snapshot
Figure 57. Middle East and Africa Next Generation Sequencing (NGS) Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 58. Middle East and Africa Next Generation Sequencing (NGS) Solution Market Size (M USD) by Country
Figure 59. Saudi Arabia Next Generation Sequencing (NGS) Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 60. UAE Next Generation Sequencing (NGS) Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 61. Egypt Next Generation Sequencing (NGS) Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 62. Nigeria Next Generation Sequencing (NGS) Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 63. South Africa Next Generation Sequencing (NGS) Solution Market Size and Growth Rate (2020-2033) & (M USD)
Figure 64. Middle East and Africa Next Generation Sequencing (NGS) Solution Market Size (M USD) by Type
Figure 65. Middle East and Africa Next Generation Sequencing (NGS) Solution Market Size (M USD) by Application
Figure 66. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 67. Global Next Generation Sequencing (NGS) Solution Market Size by Type (M USD)
Figure 68. Market Share of Next Generation Sequencing (NGS) Solution by Type (2020-2033)
Figure 69. Market Share of Next Generation Sequencing (NGS) Solution by Type in 2024
Figure 70. Global Next Generation Sequencing (NGS) Solution Growth Rate by Type (2020-2033)
Figure 71. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 72. Global Next Generation Sequencing (NGS) Solution Market Size by Application (M USD)
Figure 73. Global Next Generation Sequencing (NGS) Solution Market Share by Application
Figure 74. Global Next Generation Sequencing (NGS) Solution Market Share by Application (2020-2033)
Figure 75. Global Next Generation Sequencing (NGS) Solution Market Share by Application in 2024
Figure 76. Global Next Generation Sequencing (NGS) Solution Growth Rate by Application (2020-2033)